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Cervical sarcomas make up less than 1% of all cervical malignan-
cies and cervical leiomyosarcoma (LMS) constitutes a percentage of
that group (Khosla et al., 2012). Given the rarity of this condition,
much about cervical LMS has been extrapolated from the uterine
LMS literature and isolated case reports and case series (Khosla et
al., 2012). Uterine LMS has a poor prognosis with a median reported
survival of 10 months, a ﬁve-year overall survival (OS) of 51% and
25% for stages I and II respectively and a recurrence rate ranging
from 53 to 71% (McDonald et al., 2007). In general, cervical sarcoma
has been shown to have similar outcomes to uterine sarcoma with a
ﬁve-year OS reported as 67–80% for stage I disease and a ﬁve-year
OS of 20% for stage III (Khosla et al., 2012). The infrequency of cervical
LMS limits our insight into recurrence rates and patterns.
Vascular invasion with subsequent tumor embolization by LMS is
rare (McDonald et al., 2007). Intravascular invasion of the benign
counterpart, leiomyoma, is well-described in the literature as intra-
vascular leiomyomatosis (McDonald et al., 2007). Although pulmo-
nary tumor embolus has been described, no cases exist in the
current literature of malignant arterial tumor embolus (MATE) of
LMS to the lower extremities with resultant claudication (McDonald
et al., 2007). Furthermore, no reports have featured MATE as the ini-
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highlighting the importance of considering a metastatic work-up in
a patient with acute vascular thrombosis and a history of malignancy.
Case report
A 53-year-old womanwith a history of Stage IB2 high-grade cervical
leiomyosarcoma 5 years prior presented to an outside hospital describ-
ing three weeks of dyspnea and the acute onset of left lower extremity
(LLE) pain, coldness and paresthesia. Her cancer was primarily treated
with a radical hysterectomy and bilateral salpingo-oophorectomy
followed by 6 cycles of gemcitabine and docetaxel. Post-treatment
evaluation showed no evidence of disease. Otherwise, her medical
history was notable for diabetic vasculopathy resulting in the am-
putation of her right third toe due to chronic infections. She had
no history of thromboembolic events or claudication. Subsequent to
treatment, the patient was lost to follow-up until re-presenting with
her recurrence.
A doppler ultrasound of the LLE revealed an ankle-brachial index
(ABI) of 0.34, compatible with severe ischemia due to an obstructive
popliteal artery thrombus. She underwent an emergent popliteal endar-
terectomy. Histopathologic examination of the extracted thrombus
demonstrated a high-grade leiomyosarcoma that was diffusely positive
for desmin, smoothmuscle actin (SMA) and p16, favoring smoothmus-
cle origin of the tumor cells (Fig. 1). Computed tomography (CT) of the
chest, abdomen and pelvis also demonstratedmultiple large pulmonary
metastases in the bilateral lung ﬁelds. The abdominopelvic portion of
the CT showed no intra-abdominal foci of recurrence and no obvious
source of the left popliteal thrombus. The patient was discharged from
the hospital on therapeutic enoxaparin anti-coagulation. She was
re-treated with gemcitabine and docetaxel, with a mixed response,
and is now enrolled in a clinical trial.
Discussion
Malignant arterial tumor embolization (MATE) is a rare com-
plication of malignancy described most commonly in the setting of
primary pulmonary carcinomas and sarcomas (Chandler, 1993).
These embolizations usually occur peri-operatively or immediately
post-operatively (Chandler, 1993). Thus far, MATE as the presenting
sign of recurrent leiomyosarcoma has not been reported in the
literature; however, several circumstances surrounding this patient's
Fig. 1. Representative sections of LMS tumor thrombus (10×). (A) H & E. (B) Keratin. (C) SMA. (D) Desmin.
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ing this condition.
Venous thromboembolism (VTE) is the second leading cause of
death in patients with a malignancy (Furie and Furie, 2008). Cancer
is also a risk factor for VTE development due to pro-thrombotic fac-
tors such as tissue factor and Factor VIIa (Furie and Furie, 2008).
Arterial thrombosis is less common than venous thrombosis in pa-
tients with cancer (Khorana et al., 2008). Unlike VTE, however, the
mechanism and underlying pathophysiology of malignancy and arte-
rial thromboses are less clearly deﬁned. Arterial thrombosis is com-
monly described in the context of atherosclerotic disease leading to
ischemic stroke or myocardial infarction. While there are some phys-
ical similarities such as damage to the vascular endothelium causing
platelet activation and subsequent thrombosis, the rarity of this vas-
cular event suggests that additional mechanisms are needed for arte-
rial thrombus formation and/or embolization.
Speciﬁcally, acute arterial occlusion of the lower extremities has been
associated with atherosclerosis, inﬂammation, trauma and thrombus as-
sociatedwith exogenous graft placement (el-Shami et al., 2007). Of note,
the most common thrombosis sites have been reported to be in the
spleen, kidney and extremities, presumably due to both mechanical
forces and resultant growth factor release (el-Shami et al., 2007). Other
than atherosclerotic lesions, arterial thrombus is most commonly associ-
atedwith direct vessel trauma leading to platelet aggregation, withmin-
imal information regarding its association with malignancy. In addition
to physical trauma to the vessel, another notable source of arterial em-
bolic disease, particularly in the setting of malignancy, is embolic throm-
bi fromnonbacterial thrombotic endocarditis (el-Shami et al., 2007). This
could be the result of endothelial damage secondary to increased circu-
lating cytokines (e.g., tumor necrosis factor and interleukin-1), however,
the actual mechanism resulting in embolic phenomena remains un-
known (el-Shami et al., 2007).
Our patient presented with near complete occlusion of the popli-
teal artery. In this case, the presence of LMS in the popliteal arteryappears to be a recurrent metastatic focus. Due to the rarity of this en-
tity, the pathophysiology of a malignant tumor embolus in the setting
of recurrence is unclear. However, given our understanding of the fac-
tors leading to thrombosis, the idea of tumor thrombus as a recur-
rence is biologically plausible.
Since cancer cells can be found in human circulation without radio-
graphically detectable metastases, gross metastasis appears to depend
on a speciﬁc interaction between the cancer cell and the microenviron-
ment distant from the primary tumor (Chiang and Massague, 2008).
Several growth factors also appear important formetastasis and growth
(e.g., matrix metalloproteinases, cyclooxygenase-2, and epidermal
growth factors) (Chiang and Massague, 2008). Although the mecha-
nism remains poorly understood, individual tumor cells harbor the po-
tential to lie quiescent and, later, enter a proliferative state once they
acquire the necessary characteristics, such as angiogenesis promotion
(Almog, 2010). Some have postulated a possible interaction between
the arterial vessel wall and dormant tumor cells that leads to prolifera-
tion and, ultimately, thrombosis (Hibino et al., 2012). In cases of pulmo-
nary tumor embolism (PTTM), Hibino and colleagues hypothesize
that tumor cells obstruct small pulmonary arteries leading to cell-
mediated immune response causing intimal proliferation and larger
thrombosis (Hibino et al., 2012). Although plausible for pulmonary
tumor emboli, the samemechanismmay not apply to larger peripheral
vessels such as the popliteal artery. Since oxygen levels vary depending
on which human tissue is studied, increased hypoxia in unexpected
hypoxic regions may trigger HIF1-α, an important pro-angiogenic,
anti-apoptotic factor (Chiang and Massague, 2008). This mechanism
may be a contributing factor to the development of cancer recurrence
and metastasis speciﬁcally in tissue with less oxygenation such as in
the extremities, as seen in our patient.
Vasculature involvement by sarcomas has been reported. A
PubMed search (1993–2012) for “sarcoma” and “embolism” revealed
14 citations involving arterial embolism with only two cases of pe-
ripheral arterial emboli. No cases of LMS or arterial emboli presenting
34 K.E. Tierney et al. / Gynecologic Oncology Reports 4 (2013) 32–34as a recurrence were listed. One case of a woman with a breast ﬁbro-
sarcoma presented with bilateral lower extremity ischemia. She was
found to have bilateral femoral artery occlusion with tumor emboli
consistent with her primary breast pathology. Similar to our case,
she was found to have pulmonary metastasis, however, this entire
presentation occurred within 2 weeks of her original surgery
(Lacroix et al., 1994). This patient died 2 months following her
MATE diagnosis. There were no cases representing MATE as a recur-
rent presentation.
Although leiomyosarcomatosis has been described in the literature,
it presents as a direct extension into arterial/venous vasculature from
the primary tumor (McDonald et al., 2007). To our knowledge, this is
the ﬁrst reported case of tumor embolus of leiomyosarcoma to the pop-
liteal artery. Our patient had a history of cervical leiomyosarcoma ﬁve
years prior, thus a recurrence in the lower extremity and lungs was
the most likely diagnosis. The diagnosis of recurrence is more likely
than a diagnosis of a new primary vascular leiomyosarcoma.
In patients with a history of leiomyosarcoma presenting with
acute arterial thrombosis, MATE should be considered in the differen-
tial as a possible etiology of the thrombus. Inability to recognize the
etiology of ischemia can have catastrophic consequences including
the possibility of limb loss or death (Chandler, 1993). Speciﬁcally,
this case exposes a unique presentation of recurrent disease. The
mechanism of this phenomenon remains unclear and warrants fur-
ther investigation. Patients with risk factors for thromboembolicevents, such as cancer, should be considered candidates for indeﬁnite
anticoagulation therapy.
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